Common Contracts
4 similar Separation Agreement and Release contracts by CG Oncology, Inc.
AMENDED AND RESTATED EMPLOYMENT AGREEMENTSeparation Agreement and Release • January 2nd, 2024 • CG Oncology, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Amended and Restated Employment Agreement (this “Agreement”) is made by and between CG Oncology, Inc. (the “Company”), and Vijay Kasturi, M.D. (“Executive”) (collectively referred to herein as the “Parties” or individually referred to as a “Party”), effective as of December 13, 2023 (the “Effective Date”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTSeparation Agreement and Release • January 2nd, 2024 • CG Oncology, Inc. • Biological products, (no disgnostic substances) • Texas
This Amended and Restated Employment Agreement (this “Agreement”) is made by and between CG Oncology, Inc. (the “Company”), and Arthur Kuan (“Executive”) (collectively referred to herein as the “Parties” or individually referred to as a “Party”), effective as of December 13, 2023 (the “Effective Date”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTSeparation Agreement and Release • January 2nd, 2024 • CG Oncology, Inc. • Biological products, (no disgnostic substances) • California
This Amended and Restated Employment Agreement (this “Agreement”) is made by and between CG Oncology, Inc. (the “Company”), and Arthur Kuan (“Executive”) (collectively referred to herein as the “Parties” or individually referred to as a “Party”), effective as of March 15, 2023 (the “Effective Date”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTSeparation Agreement and Release • January 2nd, 2024 • CG Oncology, Inc. • Biological products, (no disgnostic substances) • New Jersey
This Amended and Restated Employment Agreement (this “Agreement”) is made by and between CG Oncology, Inc. (the “Company”), and Ambaw Bellete (“Executive”) (collectively referred to herein as the “Parties” or individually referred to as a “Party”), effective as of December 13, 2023 (the “Effective Date”).
